project id: TCGA-KIRC; case submitter id: TCGA-3Z-A93Z; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.03; rna integrity number: 7.0; age at index: 69; days to birth: -25205; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1944; age at diagnosis: 25205; ajcc clinical m: M0; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 385.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8310/3; primary diagnosis: Clear cell adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 134; days to sample procurement: 0; initial weight: 2080.0; portion submitter id: TCGA-3Z-A93Z-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 18.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 72.0; percent tumor nuclei: 92.0;